SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-14-067205
Filing Date
2014-11-12
Accepted
2014-11-12 16:31:58
Documents
8
Period of Report
2014-12-10
Effectiveness Date
2014-11-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A v393757_def14a.htm DEF 14A 414645
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC logo_ibio.jpg GRAPHIC 8856
4 GRAPHIC sig_elizabeth-moyle.jpg GRAPHIC 3436
5 GRAPHIC sig_robert-kay.jpg GRAPHIC 4131
6 GRAPHIC spacer.gif GRAPHIC 43
7 GRAPHIC v393757_pc1.jpg GRAPHIC 198736
8 GRAPHIC v393757_pc2.jpg GRAPHIC 217923
  Complete submission text file 0001144204-14-067205.txt   1013667
Mailing Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711
Business Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-35023 | Film No.: 141214507
SIC: 2834 Pharmaceutical Preparations